Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Breast 3Gynecologic 2Other hematologic neoplasm 1Other 1

Conditions

Obesity 30Neoplasms 12Overweight 8Breast Neoplasms 8Dyspnea 7Sexual Dysfunction, Physiological 5Mucositis 5Endometrial Neoplasms 5Pediatric Obesity 4Motor Activity 4Diabetes Mellitus, Type 2 4Weight Loss 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 3Insulin Resistance 3Uterine Cervical Neoplasms 2Syndrome 2Stomatitis 2Pulmonary Disease, Chronic Obstructive 2Pain 2Obesity-Related Malignant Neoplasm 2Obesity, Morbid 2Leukemia 2Infertility 2Fatigue 2Endometrial Hyperplasia 2Disease 2Diabetes Mellitus 2Cough 2Constipation 2

Interventions

Caloric Restriction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intermittent Fasting × Other × 90 days × Clear all
NCT05114798 2026-05-22

Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers

University of Illinois at Chicago

Phase NA Active not recruiting
193 enrolled
GastrointestinalOther

Intermittent Fasting, Obesity, Colorectal Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡